Last reviewed · How we verify
NCT04784299
To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face Volume
NA trial testing YVOIRE volume plus in Midface Volume Deficit in 105 participants. Completed in 26 October 2022.
11 April 2022
Quick facts
| Lead sponsor | LG Chem |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 105 |
| Start date | 22 March 2021 |
| Primary completion | 11 April 2022 |
| Estimated completion | 26 October 2022 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- YVOIRE volume plus
- Restylane Lyft with Lidocaine
Conditions studied
- Midface Volume Deficit — all drugs for Midface Volume Deficit →
Sponsor
LG Chem — full company profile →
Who can join
Adults 21 to 75, any sex, with Midface Volume Deficit. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A Study to Evaluate the Performance and Safety of YVOIRE volume plus for Temporary Improvement of Mid-face Volume
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04784299
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of YVOIRE volume plus
Trials testing the same drug.
- NCT04855188 — Effectiveness and Safety of YVOIRE Y-Solution 540 · NA · completed
Other LG Chem trials
Trials by the same sponsor.
- NCT07396844 — The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Voluntee · Phase 1 · not yet recruiting
- NCT07399470 — A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagl · Phase 1 · active not recruiting
- NCT07333742 — A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metfor · Phase 1 · completed
- NCT06921395 — Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulat · Phase 4 · recruiting
- NCT06743997 — A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and Tolerability · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04784299 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by LG Chem
- Last refreshed: 19 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04784299.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing